As the year winds down, medtech companies preparing to launch new surgical robots have made several advancements that suggest 2026 will be a year to watch in the rapidly evolving field.
Medtronic’s Hugo soft tissue system won Food and Drug Administration clearance earlier this month for its first indication, setting the stage for a U.S. market share battle with robotics leader Intuitive Surgical.
Days later, SS Innovations International said it filed an FDA submission seeking authorization for the SSi Mantra robot in multiple procedure types, also in the soft tissue surgical category led by Intuitive.
Another contender in the race, CMR Surgical, followed soon after with news that its Versius Plus soft tissue platform secured the FDA’s nod.
MedTech Dive is following the biggest storylines in surgical robotics. Catch up on the latest developments in this roundup:
